Literature DB >> 20656921

Expression and function of CD300 in NK cells.

Dikla Lankry1, Hrvoje Simic, Yair Klieger, Francesca Levi-Schaffer, Stipan Jonjic, Ofer Mandelboim.   

Abstract

The killing activity of NK cells is regulated by signals derived from inhibitory and activating NK cell receptors, including the CD300 family of proteins. CD300a was reported to be expressed on all NK cells and to deliver an inhibitory signal upon binding to a yet unknown ligand/s. The CD300a protein contains four ITIMs and is highly homologous to CD300c. Little is known about the function and distribution of these two receptors and the identity of their ligand/s. In this article, we show that CD300a is indeed an inhibitory receptor expressed by human NK cells, but surprisingly, we show that not all NK clones are inhibited in a CD300a-dependent manner. We demonstrate, using a panel of 13 new anti-CD300a and CD300c Abs that we generated, that CD300a and CD300c are indistinguishable on the surface of NK cells. Using mutational-analysis survey, we show that tyrosine 267 located in the third ITIM motif of the CD300a protein is important for the inhibitory function of CD300a.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20656921     DOI: 10.4049/jimmunol.0903347

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Peripheral CD300a+CD8+ T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis.

Authors:  Yi Xu; Federica Tarquini; Roberto Romero; Chong Jai Kim; Adi L Tarca; Gaurav Bhatti; JoonHo Lee; I Birgitta Sundell; Pooja Mittal; Juan Pedro Kusanovic; Sonia S Hassan; Jung-Sun Kim
Journal:  Am J Reprod Immunol       Date:  2011-11-13       Impact factor: 3.886

2.  Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells.

Authors:  Venkateswara R Simhadri; John F Andersen; Eric Calvo; Seung-Chul Choi; John E Coligan; Francisco Borrego
Journal:  Blood       Date:  2012-02-01       Impact factor: 22.113

Review 3.  The CD300 molecules: an emerging family of regulators of the immune system.

Authors:  Francisco Borrego
Journal:  Blood       Date:  2013-01-04       Impact factor: 22.113

4.  CD300a is expressed on human B cells, modulates BCR-mediated signaling, and its expression is down-regulated in HIV infection.

Authors:  Rodolfo Silva; Susan Moir; Lela Kardava; Karen Debell; Venkateswara R Simhadri; Sara Ferrando-Martínez; Manuel Leal; José Peña; John E Coligan; Francisco Borrego
Journal:  Blood       Date:  2011-04-11       Impact factor: 22.113

5.  CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines.

Authors:  Eun-Ju Kim; Sang-Min Lee; Kyoungho Suk; Won-Ha Lee
Journal:  Immunology       Date:  2012-03       Impact factor: 7.397

6.  All-trans-retinoic acid and Erk1/2 signaling synergistically regulate the expression of CD300B in human monocytic cells.

Authors:  Yong Wu; Qiuyan Chen; Tongkun Pai; A Catharine Ross
Journal:  Cell Immunol       Date:  2011-03-29       Impact factor: 4.868

7.  Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR.

Authors:  Noa Stanietsky; Tihana Lenac Rovis; Ariella Glasner; Einat Seidel; Pinchas Tsukerman; Rachel Yamin; Jonatan Enk; Stipan Jonjic; Ofer Mandelboim
Journal:  Eur J Immunol       Date:  2013-07-04       Impact factor: 5.532

8.  Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition.

Authors:  Mariko Takahashi; Kumi Izawa; Jun-ichi Kashiwakura; Yoshinori Yamanishi; Yutaka Enomoto; Ayako Kaitani; Akie Maehara; Masamichi Isobe; Shinichi Ito; Toshihiro Matsukawa; Fumio Nakahara; Toshihiko Oki; Masunori Kajikawa; Chisei Ra; Yoshimichi Okayama; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

9.  The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells.

Authors:  Dikla Lankry; Tihana Lenac Rovis; Stipan Jonjic; Ofer Mandelboim
Journal:  Eur J Immunol       Date:  2013-06-21       Impact factor: 5.532

10.  CD300A inhibits tumor cell growth by downregulating AKT phosphorylation in human glioblastoma multiforme.

Authors:  Xinrui Du; Bin Liu; Qian Ding; Dong He; Rui Zhang; Fan Yang; Haitao Fan; Liangzhu Teng; Tao Xin
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.